chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Surveillance for Rates of Pertussis Disease Among Persons Birth through 59 months of Age Receiving PENTACEL or Other Pertussis Vaccines.  This is one of 13 cases received during the surveillance period from 01 January 2010 to 23 February 2011.  Incident ID# 431223.  Initial report received on 23 February 2011 from the Investigator participating in the above-mentioned post-marketing observational surveillance study under the reference number M5A16.  A case of pertussis disease in a six-month-old female subject (initials not collected) was identified by the investigator based on review of data from the Surveillance System.  The subject's vaccine history included 3 doses of PENTACEL; lot number C3541AA received on 23 February 2010, lot number C3579AA received on 23 April 2010, and lot number C3633AA received on 22 June 2010 (routes and sites of administration not reported).  On 13 August 2010, 52 days after the last dose, she developed a cough.  On 16 August 2010, the subject developed a paroxysmal cough with a whoop.  The subject also experienced sleep disturbance.  Chest x-ray findings were negative for pneumonia.  Corrective treatments consisted of azithromycin starting on 17 August 2010 for five days.  The subject was not hospitalized.  At the time of final contact on 14 September 2010, the subject's cough had resolved.  The duration of the cough was reported at that time as 28 days.  Laboratory testing for PCR was not reported.  However, this case was epidemiologically linked to a laboratory confirmed case.  Investigator causality assessment is not required as per protocol.  Documents held by sender: None.
patient is 11 y/o she was suppose to get TDap instead she got DTap.
The day after my shot I was very tired. Each day I felt like I had the flu. I had coughing laryngitis, watery eyes. Poor appetite. After several days, I began to feel better. I did have a sore arm; but that was always the only reaction I had when I got one in the hospital I used to work at until I resigned Aug 31, 2017.
COVID 19; COVID 19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 10Dec2021 as dose 3 (booster), single (Lot number: 33030BD) at the age of 43 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: latex" (unspecified if ongoing), notes: Known allergies: latex; "Known allergies: Sulfa drugs" (unspecified if ongoing), notes: Known allergies: Sulfa drugs; "Mixed Connective Tissue Disease (auto-immune)" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 2022, outcome "unknown", COVID-19 (medically significant) with onset 2022, outcome "not recovered" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (16May2022) Positive. Therapeutic measures were taken as a result of covid-19. Clinical course included: The patient received Paxlovid as COVID-19 treatment from 08May2022 to 12May2022. She completed Paxlovid treatment on 12May2022 and had a full relapse of symptoms and positive Rapid Test on 16May2022. The patient at the time of reporting was 3 days into fully symptoms, getting worse each day. The patient did not recover.
swelling in her right foot and right calf and pain/blood clot was diagnosed in her right calf under her knee; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female patient received the second dose of bnt162b2, via an unspecified route of administration, administered in left arm on 31Mar2021 (Lot Number: ER8732) as single dose for covid-19 immunisation. There were no medical history and concomitant medications. The patient previously received the first dose of bnt162b2, at the age of 52-year-old, via an unspecified route of administration, administered in left arm on 10Mar2021 11:15(Lot Number: EN6206) as single dose for covid-19 immunization. Started experiencing swelling in her right foot and right calf and pain 3 days following 2nd injection (03Apr2021). Went to the doctor and blood clot was diagnosed in her right calf under my knee 9 days following 2nd injection (09Apr2021). Event resulted in Doctor or other healthcare professional office/clinic visit, Life threatening illness (immediate risk of death from the event). The treatment for event was 21 Days Xarelto BID then Pradaxa for 90 days. The patient was not pregnant. The outcome of the event was recovering.
This spontaneous report was received from a medical assistant referring to herself (female patient of unknown age). There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. The medical assistant reported that on an unknown date, she had touched a VAQTA vial, lot # N023953, expiry date 05-NOV-2018, for prophylaxis that was leaking and the product touched her skin directly. No adverse experiences were reported. Product Quality Complaint (PQC) was filed. Lot number N023953 has been verified to be a valid lot number for VAQTA.
This is a spontaneous report from a Pfizer-sponsored program, Pfizer RXPathways. Two contactable physicians reported that a 60-year-old male patient receive pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein) (manufacturer unknown), via an unspecified route of administration on an unspecified date at a single dose for an immunization; erythromycin (manufacturer unknown) and clarithromycin, both via an unspecified route of administration on an unspecified date at an unspecified dose and frequency for an unspecified indication; and influenza vaccine and tetanus vaccine toxoid (TETANUS VACCIN), both via an unspecified route of administrations on an unspecified date at an unspecified dose and frequency for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced drug allergies on an unknown date. The action taken in response to the event for erythromycin and clarithromycin and the outcome of the event were unknown. Pfizer is a marketing authorization holder of pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein) and erythromycin in the reporter's country. This may be a duplicate report if another marketing authorization holder of pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein) and erythromycin has submitted the same report to the regulatory authorities.
R arm localized redness, swelling, tenderness. Persistent > 3 days. Fever X 2 days, now resolved. Also bruise (over on arm appears due to restraint during vaccination).
fever of 102 high heart rate(140-170) low o2 stats (79-84)am on oxygen 3 liters could not stay awake hard time for family to wake me and exhaustion. temp lasted 4 days the other symptoms about 6 days
This spontaneous report was received from registered nurse and refers to an approximately 23 year old female patient. The patient did not have pertinent medical history, concomitant medication, drug reactions or allergies. On 31-JUL-2018, the patient was vaccinated with her first dose of GARDASIL 9 in her right deltoid, for routine vaccination (strength, dose, route, frequency, lot/batch # and expiration date were not reported). She reported that same evening, she complained of "tingling like pins and needles" in her right arm which spread through her entire body and has come and gone since. She also reported feeling fatigued and muscle weakness, on an unknown date in 2018. The patient did not need intervention to prevent serious criteria, did not performed lab diagnostics, did not present significant disability or incapacity and did not need hospitalization. The outcome of paraesthesia, fatigue and muscular weakness was reported as "ongoing". The causality assessment between paraesthesia, fatigue and muscular weakness with GARDASIL 9 was not reported.
Experienced myalgia/arthralgia, mild fever, sinus congestion and cough on 7/7/21, tested with Abbott BinaxNOW rapid antigen COVID test on 7/9/21, test was positive, progressively became more symptomatic including fatigue, loss of smell and taste, difficulty breathing. Had 2 subsequent positive rapid antigen tests, finally tested negative on day 14 after symptoms started (7/21/21).
Patient got the last dose of bactrim DS and got Covid vaccine on 10/29/23. She had developed the minor rash on chest, back that night. It spread to arms, legs, felt like electric shock entire body the next day, she came to urgent care and got prednisone on 10/30/23. The pain got worse and spread to face, neck, so she came to ER on morning of 11/1/23. They discharged her after a few hours with pain meds. She got back to ER that night due to stomach contraction ( like labor). Then the contraction spread to whole body, so much pain on skin (like sun burn) , joints, muscle, arms, fingers, bottom of feet became sensitive that she could not walk along with  the collapsing hip,  knee. Steroid was helpful for contraction but not the pain and headache. The doctor concluded the Covid 19 Pfizer and Bactrim DS triggered the reaction. She was able to sleep for 1 to 3 hours per night, got discharged on 11/10/23, and remained home care up to now.
Pt was vaccinated for covid but tested positive during inpatient admission. No vaccine information available on time, place, date, manufacturer, etc.
Patient says has a knot at injection site and a warm long welt going down the arm; at the moment is watching for progression; recommended ice/nsaid; is not seeking medical treatment at the moment.
3MM diameter hot red macule at L arm site of meningialcocal vaccine.  Also  L breast and L neck tenderness and fever of 102.
2 1/2" daimeter red, inflamed, hot area several cms below inject site on lt upper arm;
No adverse symptoms reported.; the patient received an expired dose of PROQUAD; This spontaneous report was received from a nurse and refers to a patient of unknown age. The patient's pertinent medical history, drug reactions, allergies and concomitant medication were not reported.  On 31-AUG-2020, the patient was vaccinated with expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) expiration date 25-AUG-2020 for prophylaxis (exact dose, vaccine schedule, injection site, route of administration and lot # were not provided). No adverse symptoms were reported.
ON 14TH FEBRUARY I WAS HOSPITALISED WITH A LONGITUDINAL EXTENSIVE TRANSVERSE MYELLITIS ATTACK I SPENT 5 DAYS IN HOSPITAL  I AM NOW ON MEDICATION FOR THE REST OF MY LIFE
LOW GRADE FEVER- 99.3, BODY ACHES, CHILLS, HEADACHE, MALAISE, FATIGUE,  LEFT ARM SORENESS
After I received my vaccination my tieder went down to 235 when it was 4449. After I took my Evushield injection again, I got a red and itchy rash on my arms, legs, and neck for 1-2 weeks. My doctor prescribed me topical steroid cream which didn?t help. It got better then it came back very itchy, firm, and had puss. I have been taking Benadryl every night for 3 weeks to stop the itching. I am going to a dermatologist for the rash. I went to a checkup, and I had a positive mammogram in my left breast as well. I don?t know if it cancerous yet.
Flu shot received approx 3pm on 10/8/08. Approx 10 pm, awakened with severe chills, temperature spike to 103 F. Severe headache, general malaise. In bed for two days before experiencing relief. Tylenol by mouth for treatment.
both shots made me sick; stayed in bed after the first dose; chills after the first dose; aches after the first shot; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of ILLNESS (both shots made me sick), BEDRIDDEN (stayed in bed after the first dose), CHILLS (chills after the first dose) and PAIN (aches after the first shot) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concurrent medical conditions included HIV infection NOS. Concomitant products included EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (DESCOVY) for HIV infection NOS, SILDENAFIL CITRATE (VIAGRA) for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (both shots made me sick), BEDRIDDEN (stayed in bed after the first dose), CHILLS (chills after the first dose) and PAIN (aches after the first shot). The patient was treated with IBUPROFEN at an unspecified dose and frequency and DICLOFENAC (VOLTAREN [DICLOFENAC]) at an unspecified dose and frequency. At the time of the report, ILLNESS (both shots made me sick), BEDRIDDEN (stayed in bed after the first dose), CHILLS (chills after the first dose) and PAIN (aches after the first shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-169001 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: NNI On 07-Jul-2021: Non-Significant follow up is received on 7-JUL-2021 and contains no new information.
Dizziness, Headache, Myalgia, Fever, Diarrhea, malaise, abdominal cramps Narrative:
FEVER; NIGHTMARE; DIZZINESS; DROWSINESS; NIGHT SWEATS; FATIGUE; This spontaneous report received from a patient concerned an 86 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 04-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 06-MAR-2021, the subject experienced nightmare. On 06-MAR-2021, the subject experienced dizziness. On 06-MAR-2021, the subject experienced drowsiness. On 06-MAR-2021, the subject experienced night sweats. On 06-MAR-2021, the subject experienced fatigue. On APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nightmare, dizziness, drowsiness, and night sweats on 20-MAR-2021, and fever on APR-2021, and was recovering from fatigue. This report was non-serious.
Possible GUILLIAN-BARRE per dr.  11/23/09 PCP records received for date of service 11/11/09.  Dx:  ? Guillian Barre Syndrome. Assessment:  Presents with one week hx. of dry mouth, sensitive feet, cold chills, problems with balance and waist down weakness.  Prescribed Omnicef. 12/01/09 Medical records received for DOS 11/30/09. F/U visit for ? GB syndrome Assessment: nosebleed, cough, HTN, requesting PSA test.  12/04/09 ED records received for DOS 11/17/09. Pt. presents with persistent nosebleed x 3 days. ENT consult: treated with cauterization and decongestant spray and discharged stable. DX: Acute anterior epistaxis
Initial Nausea - lasted for about 2-3 hours  Brain Fog (fuzziness, not thinking clearly) - lasted 1.5 days
DIAGNOSIS at time of disposition:   1. COVID-19 virus detected  2. Fall, initial encounter  3. Traumatic rhabdomyolysis, initial encounter (HCC)  4. Hypothermia, initial encounter  5. Atrial fibrillation with rapid ventricular response (HCC)  6. Pneumonia due to COVID-19 virus
Information has been received from a nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, concomitant medication and medical history were not provided. On 08-JUL-2015 the patient was vaccinated with an improperly stored dose of ROTATEQ (lot # K009745, expiry date 17-FEB-2016, dose and dose number were unspecified) orally. No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
in the emergency room with A-Fib; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ATRIAL FIBRILLATION (medically significant), outcome "unknown", described as "in the emergency room with A-Fib". The event "in the emergency room with a-fib" required emergency room visit. Clinical course: Patient took the vaccine and was in the emergency room with A-Fib the same day. His mom took the vaccine and ended up sick for weeks now after receiving the vaccine. His uncle took the vaccine as well and forgot who he is. He would like us to explain the bait and switch. We advertise to the people that the vaccine is approved and it's not. Comirnaty, but not everyone was taking that. A judge said that and how can we account for how that is ok. Reporter sated it was a blatant bait and switch. On advertisements even while he was on hold it says about the vaccine blah blah blah and it prevents infections and that was a lie, it does not prevent infections, people that got the vaccine are the ones getting sick and people like him that are not vaccinated are ok. It's because the vaccine is fighting your own immune system and that is why the vaccinated people have reinfection and that is a fact. The reporter stated that third thing is he hoped we realized that in a sane world that everyone that works in Pfizer should be in jail. Stated you troubled his family forever and messed with their DNA.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient reported numbness in Left arm and fingers on left hand starting shortly after receiving vaccine and still experiencing symptoms also having trouble moving arm
PATIENT CALLED TODAY AT 3:45 PM CONCERNED THAT THE VACCINATION SITE HAD DEVOPED A PAINFUL KNOTT, APPORIMATELY A QUARTER IN SIZE AREA OF SWELLING AND SOME HEAT. I RECOMENED THAT SHE HAVE IT SEEN BY A DOCTOR
Left upper arm swollen, 3-4cm indurated, tender and warm to touch. Improving by 2/25/2015, when seen in office.
Vaccine exposure during Pregnancy; Arm soreness; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during Pregnancy) and PAIN IN EXTREMITY (Arm soreness) in a 37-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for Pregnancy.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 30-Jul-2020 and the estimated date of delivery was 06-May-2021. On 12-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during Pregnancy) and PAIN IN EXTREMITY (Arm soreness). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-third week of the pregnancy.  On 12-Jan-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during Pregnancy) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication details was reported.; Sender's Comments: Based on the current available information and the temporal association between the product use and the start date of the event a causal relationship cannot be excluded.
I tested positive and had the symptoms on May 29th; scratchy throat and it went away around noon. Same thing happened on Tuesday. On Wednesday I had a little bit of a cough. Thursday I was coughing and felt like I had a fever and kept feeling worse and worse, and was tired so I slept and when I woke up felt really bad and tested which was positive. I had tested negative from Mon 29th Wed. I was out of town so I went to the emergency room and was prescribed the Pfizer pill and started it the next day. As the week progressed I got worse and worse; I ran a fever and very nauseous, and had diarrhea. The exhaustion set in and has lasted until last weekend. I am still a little tired but don't have the exhaustion where I feel like I can't take a step. I still have joint pain which I had the whole time and my joints were completely swollen. By the time I was done with the antiviral the cough was gone. I did not lose my taste or my smell.
Pt with initial dizziness (BP 84/46; HR 62; RR 20; T 94.2). Pt states she feels well, no more dizziness after 15 min (BP 107/65; HR 88; RR 20; T 97.2)
Janssen COVID-19 Vaccine EUA Patient received Johnson and Johnson vaccine on March 13, 2021 and started to develop cold/flu symptoms (cough, chills, throat pain, "rattling") around 4/20/2021. Patient came to ER and tested positive for COVID-19 on 5/3/21. Currently, being managed inpatient for COVID-19 infection.
nosebleeds 5, 7 and 9  and 10 days after -vaccine.   heavy bleeding for one hour coughing up blood clots.  Finally stopped with pressure and cold compresses.   Was on the verge of going to ER two times.  Three additional lighter nosebleeds in the morning prior to three of them .  Have not had nosebleeds for several years.  very tired.  Last one this a.m.  Fear more.
Pt recv vax on 11/18/98; on 11/21/98 pt exp diarrhea x2
Vaccine administered. Patient tolerated well but anxious throughout her visit. She complained of   sensation of tongue burning about 30 min after administration, then complained of lip numbness and  tachycardia about 60 minutes after vaccine. Symptoms resolved within an hour of onset, no worsening symptoms; BP 124/78HR 79  O2 100%;
Patient experienced shivering, racing heart and palpitations with HR up to 151 BPM. Symptoms lasted through the 24th of December.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). A patient (no qualifiers provided) received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose number unknown, single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "Fatigue". Additional information: Patient reported that they experienced fatigue after each dose of the Pfizer Covid-19 vaccine Comirnaty. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
R - ear infection, L - eye infection, gave stomas as the flu. L - arm swollen. Medicine prescribed Polymycin B Sulfate (6) Pack of antibiotic, BENADRYL, REFRESH Classic Eye Drop.
p/vax pt c/o pain & edema in hands/wrists R>L;sx started on 8/8 as achy hips, knees, hands & wrists;tx Celebrex & pred orally;sent to MD for f/u;